ArticleVaccines2023

Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines.

Catharina Gerhards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.